跳至主要内容
临床试验/JPRN-UMIN000001795
JPRN-UMIN000001795已完成3 期

Efficacy of surgery vs. radiofrequency ablation on primary hepatocellular carcinoma: a multicenter randomized controlled trial - Surgery vs. RFA for hepatocellular carcinoma: a randomized controlled trial (SURF-RCT)

Surgery vs. RFA (SURF) trial group0 个研究点目标入组 600 人开始时间: 2009年4月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 79years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Double cancer or history of other malignancy within 5 years after diagnosis 2) History of myocardial infarction or unstable angina within 6 months prior to registration 3) Patient with interstitial pneumonia, pneumofibrosis, or severe lung emphysema 4) Patient who cannot undergo enhanced CT scan due to some reason such as allergy for iodized contrast media or renal dysfunction 5) Patient with psychiatric disorder or symptom 6) Pregnant patient or patient with possibility to be pregnant

研究者

发起方
Surgery vs. RFA (SURF) trial group

相似试验